KCM

Kynam Capital Management Portfolio holdings

AUM $929M
This Quarter Return
-11.67%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$308M
AUM Growth
+$308M
Cap. Flow
+$134M
Cap. Flow %
43.61%
Top 10 Hldgs %
76.32%
Holding
36
New
3
Increased
13
Reduced
15
Closed
2

Top Buys

1
NTRA icon
Natera
NTRA
$39.3M
2
CLDX icon
Celldex Therapeutics
CLDX
$17.9M
3
TVTX icon
Travere Therapeutics
TVTX
$17.8M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
$17M
5
GBT
Global Blood Therapeutics, Inc.
GBT
$12M

Top Sells

1
XENE icon
Xenon Pharmaceuticals
XENE
$5.71M
2
ZGNX
Zogenix, Inc.
ZGNX
$3.34M
3
LQDA icon
Liquidia Corp
LQDA
$1.49M
4
COGT icon
Cogent Biosciences
COGT
$1.29M
5
KRYS icon
Krystal Biotech
KRYS
$1.09M

Sector Composition

1 Healthcare 99.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CABA icon
26
Cabaletta Bio
CABA
$133M
$1.25M 0.41%
616,125
-28,458
-4% -$57.8K
KRYS icon
27
Krystal Biotech
KRYS
$4.27B
$1.22M 0.4%
18,393
-16,423
-47% -$1.09M
OLMA icon
28
Olema Pharmaceuticals
OLMA
$375M
$1.2M 0.39%
280,827
-12,972
-4% -$55.2K
CNTB
29
Connect Biopharma
CNTB
$115M
$688K 0.22%
+227,759
New +$688K
NGNE icon
30
Neurogene
NGNE
$264M
$264K 0.09%
140,508
-6,492
-4% -$12.2K
GYRE icon
31
Gyre Therapeutics
GYRE
$703M
$70K 0.02%
106,089
-4,902
-4% -$3.23K
ALLK
32
DELISTED
Allakos
ALLK
– –
0
– –
COGT icon
33
Cogent Biosciences
COGT
$1.69B
– –
-150,000
Closed -$1.29M
NKTR icon
34
Nektar Therapeutics
NKTR
$568M
– –
0
– –
TGTX icon
35
TG Therapeutics
TGTX
$4.65B
– –
0
– –
ZGNX
36
DELISTED
Zogenix, Inc.
ZGNX
– –
-205,800
Closed -$3.34M
1
2